Solara Pharma Rights Issue Second Final Call

Solara Active Pharma's Rights Issue Committee approved a Second & Final call of ₹112.50 per partly-paid Rights Share on March 24, 2026.
The call comprises ₹3.00 towards face value and ₹109.50 towards securities premium, pursuant to Letter of Offer dated May 09, 2024.
Record date for determining eligible partly paid-up equity shareholders fixed as April 02, 2026 for dispatch of call notices.